术前肾动脉栓塞对直径≥10 cm肾细胞癌手术安全性的影响
该回顾性研究分析了239例肿瘤最大径≥10 cm的肾细胞癌手术患者,其中53例术前行肾动脉栓塞,186例未行。结果显示栓塞组输血量较低,但住院时间更长、ICU入住率更高,手术时间与并发症发生率无显著差异。
要点
- 术前肾动脉栓塞可降低直径≥10 cm肾细胞癌患者的输血量。
- 栓塞组住院时间更长且ICU入住率更高,需权衡获益与资源使用。
- 两组手术时间与围术期并发症发生率无显著差异。
核心结论
- 术前肾动脉栓塞可增加大体积肾肿瘤手术安全性并降低围术期死亡风险。
研究设计与样本
- 回顾性分析2002年1月至2014年12月北京大学第一医院泌尿外科行手术治疗的肿瘤最大径≥10 cm肾细胞癌患者239例,治疗组53例行术前肾动脉栓塞,对照组186例未行。
主要发现
- 治疗组开放手术比例高于对照组(96.2%比82.3%,χ²=6.438,P=0.013)。
- 两组手术时间无显著差异(238(525)min比208(583)min,Z=-2.182,P=0.062)。
- 治疗组输血量低于对照组(700(1 900)ml比925(8 800)ml,Z=-1.064,P=0.006)。
- 治疗组住院时间更长(21(50)d比15(79)d,Z=-4.322,P=0.000),ICU入住率更高(54.7%比34.4%,χ²=6.103,P=0.027)。
- 两组围术期并发症发生率无显著差异(0比3.2%,P=0.408)。
临床怎么用
- 对直径≥10 cm肾细胞癌患者,术前肾动脉栓塞可能减少术中输血,但需注意住院时间和ICU资源使用增加。
局限性
- 本研究为单中心回顾性分析,两组肿瘤位置存在差异,且治疗组开放手术比例更高,可能影响结果解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To study the impact to operation safety of preoperative renal artery embolization for management of ≥10 cm renal cell carcinoma. Methods: The clinical data of 239 cases with ≥10 cm renal cell carcinoma which all had underwent operation in Department of Urology, Peking University First Hospital from January 2002 to December 2014 were retrospectively analyzed. Fifty-three patients underwent preoperative renal artery embolization (therapeutic group) and 186 patients did not (control group). The effect of embolization on operative time, transfusion requirements, hospitalization, ICU stay and perioperative complications were analyzed by comparing the two groups using rank sum test and χ(2) test or Fisher exact test. Results: Comparing the therapeutic group and control group, there was significant difference in tumor location (on the left or right). The mean age, sex, mean primary tumor size, and TNM stage were similar in both groups. Comparing the therapeutic group and control group, there were more open surgeries in therapeutic group (96.2% vs. 82.3%, χ(2)=6.438, P=0.013). There were no significant differences in mean operative time (238 (525) minutes vs. 208 (583) minutes, Z=-2.182, P=0.062). The mean blood transfusion (700 (1 900) ml vs. 925 (8 800) ml, Z=-1.064, P=0.006) had significant difference. The therapeutic group had a longer mean hospitalization (21 (50) days vs. 15 (79) days, Z=-4.322, P=0.000) and higher rate of intensive care unit stay (54.7% vs. 34.4%, χ(2)=6.103, P=0.027). There was no significant difference in perioperative complications between two groups (0 vs.3.2%, P=0.408). Conclusion: Preoperative renal artery embolization in ≥10 cm renal cell carcinoma patients undergoing operation provides benefit in increasing operation safety and reducing perioperative death. 目的: 探讨术前肾动脉栓塞治疗对肿瘤最大径≥10 cm的肾细胞癌患者手术安全性的影响。 方法: 回顾性分析2002年1月至2014年12月于北京大学第一医院泌尿外科行手术治疗的肿瘤最大径≥10 cm的肾细胞癌患者239例,根据术前是否行肾动脉栓塞治疗分为治疗组(53例)和对照组(186例)。比较两组患者的手术时间、输血量、住院时间、手术并发症情况。定量资料组间比较采用秩和检验,分类资料组间比较采用χ(2)检验或Fisher精确概率检验。 结果: 除肿瘤位置(左侧/右侧)外,治疗组与对照组临床资料的差异无统计学意义(P>0.05)。手术结果方面,治疗组开放手术比例高于对照组(96.2%比82.3%,χ(2)=6.438,P=0.013)。两组手术时间[M(Q(R)),238(525)min比208(583)min,Z=-2.182,P=0.062]、输血(自体血及异体血)比例(26.4%比32.3%,χ(2)=8.239,P=0.318)差异均无统计学意义,治疗组输血量低于对照组[700(1 900)ml比925(8 800)ml,Z=-1.064,P=0.006]。治疗组的住院时间短于对照组[21(50)d比15(79)d,Z=-4.322,P=0.000],入住ICU患者比例高于对照组(54.7%比34.4%,χ(2)=6.103,P=0.027),而并发症发生率差异无统计学意义(0比3.2%,P=0.408)。 结论: 术前肾动脉栓塞治疗可以增加大体积肾肿瘤手术的安全性,并降低围手术期死亡的风险。.
引用
- Jia Z, Li XS, Zhang CJ, et al. [The impact to operation safety of preoperative renal artery embolization for management of diameter≥10 cm renal cell carcinoma]. Zhonghua Wai Ke Za Zhi. 2017. PMID: 29050172. doi:10.3760/cma.j.issn.0529-5815.2017.10.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。